The developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the United States for clinical trials and use.

The Walt Disney Co. uses a complex network of companies and subsidiaries to move profits out of high-tax countries to the tiny nation of Luxembourg, where the multinational giant only pays an effective tax rate of 0.3 percent.

A state program that shells out big bucks to private companies in the hopes they will create jobs in Florida is under scrutiny, again. The Tampa Bay Times/Miami Herald reports the program isn’t getting the return on investment taxpayers were promised.